X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.prnewswire.com/news-releases/us-worldmeds-reaches-agreement-with-walgreens-to-make-immediately-available-lucemyra-lofexidine-in-pharmacies-across-the-nation-301365639.html
https://www.prnewswire.com/news-releases/us-worldmeds-announces-partnership-with-fema-and-healthcare-ready-during-coronavirus-pandemic-301090964.html
https://www.fiercepharma.com/marketing/cosmo-to-give-bausch-health-sales-a-run-latest-fda-nod-for-xifaxan-rival
https://www.fiercepharma.com/pharma/valeant-s-salix-signs-to-hawk-opioid-withdrawal-drug-lucemyra-alongside-relistor
https://www.in-pharmatechnologist.com/Article/2018/05/24/Catalent-made-Lucemyra-wins-US-FDA-approval-for-opioid-withdrawal
https://endpts.com/fda-approves-first-non-opioid-to-treat-withdrawal-symptoms-in-adults/
https://www.fiercepharma.com/pharma/fda-approves-lucemyra-first-med-to-ease-symptoms-opioid-withdrawal
https://www.businessinsider.in/The-government-has-approved-the-first-treatment-for-a-key-factor-in-the-drug-overdose-crisis-which-kills-more-people-than-car-crashes/articleshow/64197735.cms
https://www.reuters.com/article/us-fda-approval/fda-approves-first-non-opioid-drug-to-treat-opioid-withdrawal-symptoms-idUSKCN1IH30J
https://www.prnewswire.com/news-releases/fda-approves-us-worldmeds-lucemyra-lofexidine-after-priority-review-for-the-management-of-opioid-withdrawal-symptoms-300649939.html
https://www.prnewswire.com/news-releases/fda-advisory-committee-votes-in-favor-of-lucemyra-lofexidine-for-the-mitigation-of-opioid-withdrawal-symptoms-300620526.html
Market Place
Share 
